213 related articles for article (PubMed ID: 22842565)
1. Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.
Shiraishi D; Fujiwara Y; Komohara Y; Mizuta H; Takeya M
Biochem Biophys Res Commun; 2012 Aug; 425(2):304-8. PubMed ID: 22842565
[TBL] [Abstract][Full Text] [Related]
2. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
4. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
5. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
Cheong YH; Kim MK; Son MH; Kaang BK
Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
[TBL] [Abstract][Full Text] [Related]
6. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M
PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression.
Kim Chung le T; Hosaka T; Yoshida M; Harada N; Sakaue H; Sakai T; Nakaya Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):613-8. PubMed ID: 19850014
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
9. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages.
Fujiwara Y; Komohara Y; Ikeda T; Takeya M
Cancer Sci; 2011 Jan; 102(1):206-11. PubMed ID: 21073634
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
Schlatter P; Beglinger C; Drewe J; Gutmann H
Regul Pept; 2007 Jun; 141(1-3):120-8. PubMed ID: 17276524
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
Ishibashi Y; Nishino Y; Matsui T; Takeuchi M; Yamagishi S
Metabolism; 2011 Sep; 60(9):1271-7. PubMed ID: 21388644
[TBL] [Abstract][Full Text] [Related]
12. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
[TBL] [Abstract][Full Text] [Related]
13. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes.
Montrose-Rafizadeh C; Yang H; Wang Y; Roth J; Montrose MH; Adams LG
J Cell Physiol; 1997 Sep; 172(3):275-83. PubMed ID: 9284947
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis.
Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Glaser S; Benedetti A
Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 Induces Bone Marrow Stromal Cells Migration Through Bone Marrow-Derived Macrophages Polarization via PKA-STAT3 Signaling Pathway.
Wang N; Gao J; Jia M; Ma X; Lei Z; Da F; Yan F; Zhang H; Zhou Y; Li M; He G; Meng J; Luo X
Cell Physiol Biochem; 2017; 44(5):1696-1714. PubMed ID: 29216639
[TBL] [Abstract][Full Text] [Related]
16. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.
van Genugten RE; van Raalte DH; Diamant M
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S26-34. PubMed ID: 20115929
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA.
Oliver E; McGillicuddy FC; Harford KA; Reynolds CM; Phillips CM; Ferguson JF; Roche HM
J Nutr Biochem; 2012 Sep; 23(9):1192-200. PubMed ID: 22137266
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 upregulates visfatin expression in 3T3-L1 adipocytes.
Liu R; Ding X; Wang Y; Wang M; Peng Y
Horm Metab Res; 2013 Sep; 45(9):646-51. PubMed ID: 23670349
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages.
Guo C; Huang T; Chen A; Chen X; Wang L; Shen F; Gu X
Braz J Med Biol Res; 2016 Nov; 49(12):e5826. PubMed ID: 27878229
[TBL] [Abstract][Full Text] [Related]
20. The activation state of macrophages alters their ability to suppress preadipocyte apoptosis.
Molgat AS; Gagnon A; Foster C; Sorisky A
J Endocrinol; 2012 Jul; 214(1):21-9. PubMed ID: 22556272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
